Effect of Probiotics Containing Yogurts on the Composition of Biofilms in Patients Under Orthodontic Treatment
Effects of Yogurt Containing Bifidobacterium Animalis Ssp. Lactis dn- 1173010 Probiotics in the Composition of Biofilms and Saliva of Orthodontic Patients: a Crossover, Double-blind, Randomized and Placebo Controlled Clinical Trial.
1 other identifier
interventional
30
1 country
1
Brief Summary
Aim: To assess in vivo if the intake of yogurt containing Bifidobacterium animalis ssp. lactis DN- 1173010 probiotic for a period of 2 weeks affects the salivary levels or biofilms of mutans streptococci and the lactobacilli of patients undergoing orthodontic treatment. Methods: A crossover, double-blind, randomized and placebo controlled clinical trial will be performed with 26 volunteers during 4 periods. During periods 2 and 4 (2 weeks each) the volunteers will have a daily ingestion of yogurt containing probiotic or of control yogurt which did not contain probiotic. Periods 1 and 3 were run-in and wash-out periods of 1 and 4 weeks, respectively. Experimental samples of saliva and biofilm will be collected from each participant at the end of each phase. Mutans streptococci, lactobacilli, total aciduric microorganisms, Candida spp. and total cultivable microorganisms will be counted. The values before and after the treatment will be compared with Wilcoxon's test (p\<0.05).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 2, 2012
CompletedFirst Posted
Study publicly available on registry
August 6, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedSeptember 18, 2013
September 1, 2013
1 year
August 2, 2012
September 17, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Cariogenic bacteria reduction
The amount of cariogenic bacteria (mutans streptococci and lactobacilli) will be evaluated before and after the treatments for each patient
14 days
Secondary Outcomes (1)
Patient discomfort with the treatment
14 days after intervention
Study Arms (2)
Probiotics
EXPERIMENTALGroup of patients using yogurt containing probiotics during the experimental phase of the study.
Control Yogurt
PLACEBO COMPARATORGroup of patients that will use a placebo yogurt for providing comparison with the experimental group.
Interventions
patients assigned to this group will use a yogurt containing Bifidobacterium animalis once a day during 14 days before evaluation of the outcomes.
Patients will use a yogurt without probiotics once a day during 14 days before evaluation of outcomes
Eligibility Criteria
You may qualify if:
- excellent oral health
- patients under bimaxillary orthodontic treatment
You may not qualify if:
- any chronic disease
- antibiotics and/or antimicrobial use in the previous 3 weeks
- topic fluoride or chlorhexidine use in the previous 3 weeks
- presence of cavitated or active carious lesions
- patients with intolerance to lactose.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Graduate Program in Dentistry, Federal University of Pelotas
Pelotas, Rio Grande do Sul, 96015560, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Maximiliano S Cenci, PhD
Graduate Program in Dentistry, Federal University of Pelotas
- PRINCIPAL INVESTIGATOR
Gabriela S Pinto, MSc
Graduate Program in Dentistry, Federal University of Pelotas
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Coordinator of Clinical Trial, Graduate of Program of Dentistry
Study Record Dates
First Submitted
August 2, 2012
First Posted
August 6, 2012
Study Start
August 1, 2011
Primary Completion
August 1, 2012
Study Completion
March 1, 2013
Last Updated
September 18, 2013
Record last verified: 2013-09